Search

Search Constraints

You searched for: Author/Creator Maric, Dragan

Search Results

21. EXTH-76. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA NEUROSPHERES TO TEMOZOLOMIDE. (14th November 2022)

22. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. (7th July 2015)

23. Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma. Issue 11 (23rd October 2019)

24. IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation. Issue 9 (5th January 2022)

25. Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma. Issue 9 (8th February 2021)

26. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Issue 3 (1st February 2016)

27. IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes. (7th November 2013)

28. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. (28th February 2018)

29. Longitudinal peripheral tissue RNA‐Seq transcriptomic profiling, hyperalgesia, and wound healing in the rat plantar surgical incision model. Issue 10 (9th September 2021)

30. MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment. Issue 1 (3rd June 2020)